• Rivaroxaban is approved by NICE for the prevention of stroke and embolisms
  • In 2009, a study on the blood thinner appeared to show it was safe and effective
  • But now medical journal The Lancet has warned of ‘inaccuracies’ in the trial data

https://www.dailymail.co.uk/health/article-11609501/Anti-stroke-drug-taken-millions-unreliable-fatal-effects-ignored.html

NB: often sold under the brand name Xarelto